• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.莱姆病从早期到晚期阶段人类B细胞对伯氏疏螺旋体VlsE蛋白的表位特异性进化
J Immunol. 2016 Feb 1;196(3):1036-43. doi: 10.4049/jimmunol.1501861. Epub 2015 Dec 30.
2
Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes.有证据表明,在莱姆病螺旋体感染期间,VlsE中央结构域的可变区具有抗原性。
Infect Immun. 2002 Aug;70(8):4196-203. doi: 10.1128/IAI.70.8.4196-4203.2002.
3
Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.在VlsE介导的免疫逃逸情况下对莱姆病螺旋体的抗体反应。
Infect Immun. 2016 Dec 29;85(1). doi: 10.1128/IAI.00890-16. Print 2017 Jan.
4
Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.鉴定与高度免疫逃逸 VlsE 表达莱姆病螺旋体保护相关的表面表位。
Infect Immun. 2018 Jul 23;86(8). doi: 10.1128/IAI.00182-18. Print 2018 Aug.
5
Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.对莱姆病后综合征患者体内针对伯氏疏螺旋体 VlsE 蛋白的抗体进行表位作图。
Clin Immunol. 2011 Oct;141(1):103-10. doi: 10.1016/j.clim.2011.06.005. Epub 2011 Jul 2.
6
Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.伯氏疏螺旋体C6诊断肽的主要表位在亲本VlsE分子上基本无法被抗体识别。
Clin Vaccine Immunol. 2007 Aug;14(8):931-6. doi: 10.1128/CVI.00075-07. Epub 2007 Jun 13.
7
Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.用常见莱姆病疫苗接种的犬只对IR6无反应,IR6是伯氏疏螺旋体VlsE表面蛋白的保守免疫显性区域。
Clin Diagn Lab Immunol. 2004 May;11(3):458-62. doi: 10.1128/CDLI.11.3.458-462.2004.
8
Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.人类对伯氏疏螺旋体VlsE抗原变异蛋白的抗体反应。
J Clin Microbiol. 1999 Dec;37(12):3997-4004. doi: 10.1128/JCM.37.12.3997-4004.1999.
9
Immune responses to borrelial VlsE IR6 peptide variants.对疏螺旋体VlsE IR6肽变体的免疫反应。
Int J Med Microbiol. 2007 Feb;297(1):45-52. doi: 10.1016/j.ijmm.2006.09.001. Epub 2007 Jan 17.
10
Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease.莱姆病成功抗生素治疗后,针对伯氏疏螺旋体VlsE第六恒定区(IR6)肽的抗体反应持续存在。
J Infect Dis. 2003 Apr 15;187(8):1178-86. doi: 10.1086/374376. Epub 2003 Apr 2.

引用本文的文献

1
Class and isotype of VlsE-specific antibody differentiates Lyme disease stage.VlsE特异性抗体的类别和同种型可区分莱姆病的阶段。
J Clin Microbiol. 2025 Aug 13;63(8):e0034725. doi: 10.1128/jcm.00347-25. Epub 2025 Jul 15.
2
Borrelia surface proteins: new horizons in Lyme disease diagnosis.疏螺旋体表面蛋白:莱姆病诊断的新视野
Appl Microbiol Biotechnol. 2025 Jul 1;109(1):156. doi: 10.1007/s00253-025-13490-6.
3
A Refined Human Linear B Cell Epitope Map of Outer Surface Protein C (OspC) From the Lyme Disease Spirochete, .来自莱姆病螺旋体的外表面蛋白C(OspC)的精细人线性B细胞表位图谱
Pathog Immun. 2025 Feb 14;10(1):159-186. doi: 10.20411/pai.v10i1.756. eCollection 2024.
4
A portable immunosensor provides sensitive and rapid detection of Borrelia burgdorferi antigen in spiked blood.一种便携式免疫传感器可灵敏、快速地检测血样中的伯氏疏螺旋体抗原。
Sci Rep. 2023 May 9;13(1):7546. doi: 10.1038/s41598-023-34108-9.
5
Evolution of the Antigenic Variability Locus of the Lyme Disease Pathogen and Development of Recombinant Monoclonal Antibodies Targeting Conserved VlsE Epitopes.莱姆病病原体抗原变异性基因座的演变和针对保守 VlsE 表位的重组单克隆抗体的开发。
Microbiol Spectr. 2022 Oct 26;10(5):e0174322. doi: 10.1128/spectrum.01743-22. Epub 2022 Sep 23.
6
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.免疫球蛋白 G 血清动力学辅助宿主特异性线性表位鉴定和感染与接种宿主的区分。
J Virol. 2022 Jul 13;96(13):e0014322. doi: 10.1128/jvi.00143-22. Epub 2022 Jun 6.
7
Laboratory Diagnosis of Lyme Borreliosis.莱姆病的实验室诊断。
Clin Microbiol Rev. 2021 Jan 27;34(2). doi: 10.1128/CMR.00018-19. Print 2021 Mar 17.
8
Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex Format.血清表位谱分析可提高敏感性,以可扩展的多重格式实现莱姆病的早期检测。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.01836-20.
9
A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.用于即时检测的用于莱姆病诊断的多重血清学检测。
J Clin Microbiol. 2019 Nov 22;57(12). doi: 10.1128/JCM.01142-19. Print 2019 Dec.
10
Detection of a Low Level and Heterogeneous B Cell Immune Response in Peripheral Blood of Acute Borreliosis Patients With High Throughput Sequencing.高通量测序检测急性伯氏疏螺旋体病患者外周血中低水平和异质性 B 细胞免疫反应。
Front Immunol. 2019 May 16;10:1105. doi: 10.3389/fimmu.2019.01105. eCollection 2019.

本文引用的文献

1
Lyme disease testing by large commercial laboratories in the United States.美国大型商业实验室进行的莱姆病检测。
Clin Infect Dis. 2014 Sep 1;59(5):676-81. doi: 10.1093/cid/ciu397. Epub 2014 May 30.
2
Variable VlsE is critical for host reinfection by the Lyme disease spirochete.可变 VlsE 对于莱姆病螺旋体引起宿主再感染至关重要。
PLoS One. 2013 Apr 8;8(4):e61226. doi: 10.1371/journal.pone.0061226. Print 2013.
3
Lyme disease: a multisystem infection that affects the nervous system.莱姆病:一种影响神经系统的多系统感染。
Continuum (Minneap Minn). 2012 Dec;18(6 Infectious Disease):1338-50. doi: 10.1212/01.CON.0000423850.24900.3a.
4
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.在有莱姆病病史和持续认知障碍的患者中,IFNα 活性增加和抗体反应的差异。
J Neuroimmunol. 2013 Feb 15;255(1-2):85-91. doi: 10.1016/j.jneuroim.2012.10.011. Epub 2012 Nov 8.
5
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.采用 C6 肽 ELISA 试剂盒进行单阶段检测与莱姆病的双阶段检测相比。
Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11.
6
In the clinic. Lyme disease.在临床上。莱姆病。
Ann Intern Med. 2012 Aug 7;157(3):ITC2-2 - ITC2-16. doi: 10.7326/0003-4819-157-3-201208070-01002.
7
Lyme borreliosis.莱姆病。
Lancet. 2012 Feb 4;379(9814):461-73. doi: 10.1016/S0140-6736(11)60103-7. Epub 2011 Sep 6.
8
Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.对莱姆病后综合征患者体内针对伯氏疏螺旋体 VlsE 蛋白的抗体进行表位作图。
Clin Immunol. 2011 Oct;141(1):103-10. doi: 10.1016/j.clim.2011.06.005. Epub 2011 Jul 2.
9
Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.伯氏疏螺旋体 RST1(OspC 型 A)基因型与更大的炎症和更严重的莱姆病有关。
Am J Pathol. 2011 Jun;178(6):2726-39. doi: 10.1016/j.ajpath.2011.02.018.
10
Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.莱姆病后综合征中的抗伯氏疏螺旋体抗体谱
Clin Vaccine Immunol. 2011 May;18(5):767-71. doi: 10.1128/CVI.00002-11. Epub 2011 Mar 16.

莱姆病从早期到晚期阶段人类B细胞对伯氏疏螺旋体VlsE蛋白的表位特异性进化

Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

作者信息

Jacek Elzbieta, Tang Kevin S, Komorowski Lars, Ajamian Mary, Probst Christian, Stevenson Brian, Wormser Gary P, Marques Adriana R, Alaedini Armin

机构信息

Department of Medicine, Columbia University Medical Center, New York, NY 10032;

Institute for Experimental Immunology, Euroimmun AG, D-23560 Lubeck, Germany;

出版信息

J Immunol. 2016 Feb 1;196(3):1036-43. doi: 10.4049/jimmunol.1501861. Epub 2015 Dec 30.

DOI:10.4049/jimmunol.1501861
PMID:26718339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4722499/
Abstract

Most immunogenic proteins of Borrelia burgdorferi, the causative agent of Lyme disease, are known or expected to contain multiple B cell epitopes. However, the kinetics of the development of human B cell responses toward the various epitopes of individual proteins during the course of Lyme disease has not been examined. Using the highly immunogenic VlsE as a model Ag, we investigated the evolution of humoral immune responses toward its immunodominant sequences in 90 patients with a range of early to late manifestations of Lyme disease. The results demonstrate the existence of asynchronous, independently developing, Ab responses against the two major immunogenic regions of the VlsE molecule in the human host. Despite their strong immunogenicity, the target epitopes were inaccessible to Abs on intact spirochetes, suggesting a lack of direct immunoprotective effect. These observations document the association of immune reactivity toward specific VlsE sequences with different phases of Lyme disease, demonstrating the potential use of detailed epitope mapping of Ags for staging of the infection, and offer insights regarding the pathogen's possible immune evasion mechanisms.

摘要

莱姆病的病原体伯氏疏螺旋体的大多数免疫原性蛋白已知或预期含有多个B细胞表位。然而,在莱姆病病程中,人类B细胞针对单个蛋白的各种表位产生应答的动力学尚未得到研究。我们以高度免疫原性的VlsE作为模型抗原,调查了90例具有一系列莱姆病早期至晚期表现的患者针对其免疫显性序列的体液免疫应答的演变情况。结果表明,在人类宿主中,针对VlsE分子的两个主要免疫原性区域存在异步、独立发展的抗体应答。尽管其具有很强的免疫原性,但完整螺旋体上的抗体无法接近靶表位,这表明缺乏直接的免疫保护作用。这些观察结果证明了针对特定VlsE序列的免疫反应性与莱姆病不同阶段的关联,证明了详细的抗原表位图谱在感染分期中的潜在用途,并提供了有关病原体可能的免疫逃避机制的见解。